Inventor · disambiguated record
Stephen R. Byrn
Also filed as: BYRN STEPHEN R · BYRN STEPHEN ROBERT
6 granted patents·8 pending applications·122 citations·filing 2001–2025
81Inventor score
Top patents by PatentIndex Score
14 records- 0196US6605729B1Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2002·Granted Aug 12, 2003·104 cites·15 claims
- 0280US7144915B2Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2003·Granted Dec 5, 2006·9 cites·46 claims
- 0374US7244748B2Pyridines for treating injured mammalian nerve tissuePURDUE RESEARCH FOUNDATION·Filed 2003·Granted Jul 17, 2007·7 cites·10 claims
- 0472US8097638B2Pyridines for treating injured mammalian nerve tissueBORGENS RICHARD B·Filed 2007·Granted Jan 17, 2012·2 cites·9 claims
- 0565US2008287521A1Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)PFIZER·Filed 2008·Application pending·0 cites
- 0663US12318370B2Processes for preparing solid state formsVARDA SPACE IND INC·Filed 2024·Granted Jun 3, 2025·0 cites·20 claims
- 0763US2008214651A1Crystalline forms of [R-(R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)PFIZER·Filed 2007·Application pending·0 cites
- 0851US2021260058A1Nilotinib Compositions with Enhanced SolubilityNEOFORM BIOPHARMACEUTICAL LTD·Filed 2021·Application pending·0 cites
- 0951US2005176735A1Polymorphs of zaleplon and methods for the preparation thereofFiled 2004·Application pending·0 cites
- 1049US2025360110A1Processes for preparing solid state formsVARDA SPACE IND INC·Filed 2025·Application pending·0 cites
- 1147US8729107B2Pyridines for treating injured mammalian nerve tissueBORGENS RICHARD B·Filed 2010·Granted May 20, 2014·0 cites·11 claims
- 1241US2024115576A1Caffeine CompositionsOYE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1341US2002072527A1Polymorphs of zaleplon and methods for the preparation thereofSSCI INC·Filed 2001·Application pending·0 cites
- 1437US2023066204A1Caffeine Citrate FormulationsOYE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →